A qPCR-based approach targeting the microbial gene marker nanA of mucin-degrading Akkermansia in Parkinson's disease
Yasuaki Mizutani, Tadashi Fujii, Yasuhiro Maeda, Kohei Funasaka, Eizaburo Ohno, Yoshiki Hirooka, Hirohisa Watanabe, Takumi TochioBackground
Parkinson's disease (PD) is a multifactorial neurodegenerative disorder increasingly linked to gut microbiota alterations. However, despite advances in fecal microbiota profiling as a non-invasive approach to disease risk assessment, its clinical utility remains limited by a lack of functionally relevant microbial biomarkers.
Objective
This cross-sectional study aimed to identify a microbial gene marker reflecting metabolic potential associated with both the presence and severity of PD.
Methods
Fecal samples from patients with PD (
Results
Patients with PD showed reduced abundance of short-chain fatty acid-producing taxa (
Conclusions
We have identified